Search Results

Displaying Results 226-250 of 1129 "'WU'"

Apr 02, 2026, 20:13 ET Your Body Thinks It's Protecting You. What If It's Wrong?

best-selling author Lisa Feldman Barrett, PhD, neuroscientist and NYU Dean Wendy Suzuki, PhD, futures designer Nick Foster, RDI, sleep psychologist Jade Wu, PhD, broadcaster and author Krista Tippett, and on Thursday, April 2, will have a Spark Salon with journalist and author Eliot Stein.

More news about: Unlikely Collaborators


Apr 01, 2026, 20:00 ET CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala

2026 Awards, representing the CHIC Founding Individuals and the Organizing Committee & Working Group.FoundersMarietta Wu, Managing Director, Quan CapitalFrank Kung, Managing Partner, Vivo CapitalHongbo Lu, Managing Member, NEXTBio CapitalJames

More news about: PharmaDJ


Apr 01, 2026, 07:30 ET 4,000 Youths Find a Home with Zero Cost in Gui'an

here I feel secure. The room is well-decorated and fully furnished, and it's close to the subway station, which is very convenient." After graduating, Wu Lei became one of the first residents of the Anchao • Yunlan community. The community offers fully furnished and smart-equipped apartments, with shared

More news about: Discover Guizhou


Mar 31, 2026, 08:27 ET Sands China Concludes Successful Participation at Art Central

private, corporate, and institutional collections worldwide.Media contacts:Corporate Communications, Sands China Ltd.Mabel WuTel: +853 8118 2268Email: [email protected]

More news about: Sands China Ltd.


Mar 29, 2026, 08:55 ET The "Artificial Intelligence + Industry" Forum 2026: AI Facilitates Industrial Transformation

Technology, and organized by Science and Technology Daily (S&T Daily) and the Institute of Scientific and Technical Information of China.Wu Jing, president of S&T Daily, said the forum was a concrete measure to carry out the national strategic deployment to accelerate the development

More news about: Science and Technology Daily


Mar 29, 2026, 06:34 ET Pharos Network and Circle to Bring USDC and CCTP to Upcoming Mainnet, Powering a RealFi Settlement Layer

freely across ecosystems while supporting more efficient liquidity management and cross-chain distribution of tokenized real-world assets.Wish Wu of the Pharos Foundation said: "RealFi requires both trusted settlement and global accessibility. The integration of USDC and CCTP can bring institutional-grade

More news about: Pharos Network


Mar 28, 2026, 16:45 ET REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS

https://doi.org/10.3390/jcdd11040120Domanski MJ, Tian X, Wu CO, et al. Time course of LDL cholesterol exposure and cardiovascular disease event risk. J Am Coll Cardiol. 2024;76(13):1507-1516.Kalra

More news about: Amgen


Mar 28, 2026, 12:36 ET Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting

that may be made from time to time, whether as a result of new information, future developments or otherwise.For Investors:Vivian Wu[email protected] Davis, Ph.D.LifeSci

More news about: Nektar Therapeutics


Mar 27, 2026, 17:00 ET /C O R R E C T I O N -- W.W. Grainger, Inc./

Supplier of the Year: EssitySustainability Supplier: Schneider ElectricExcellence in Partnership (Individual): Teresa Wu, 3MSourcing Partner: Husky Rack & WireContact of the Year (Individual): Brandon Sonich, Elkay Inc.Carrier/Transportation

More news about: W.W. Grainger, Inc.


Mar 27, 2026, 09:00 ET UCB Presents New BIMZELX® (bimekizumab-bkzx) Data at AAD Demonstrating High Rates of Durable and Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis

Lebwohl M, et al. Bimekizumab versus Secukinumab in Plaque Psoriasis. N Engl J Med. 2021;385(2):142–52.5. Armstrong AW, Schupp C, Wu J, et al. Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011.

More news about: UCB


Mar 27, 2026, 08:39 ET Dizal's ZEGFROVY® (Sunvozertinib) Shows Profound Antitumor Activity as First-Line Treatment in Advanced NSCLC Patients with PACC or Other Uncommon Mutations at ELCC 2026

platinum-based chemotherapy. The approval in China is based on the results of the pivotal WU-KONG6 study in platinum-based chemotherapy pretreated NSCLC with EGFR exon20ins. The U.S. approval is supported by WU-KONG1 Part B, a multinational pivotal study investigating the efficacy and safety of ZEGFROVY

More news about: Dizal


Mar 26, 2026, 13:30 ET Unlikely Collaborators Hosts Journalist and Author Eliot Stein

best-selling author Lisa Feldman Barrett, PhD, neuroscientist and NYU Dean Wendy Suzuki, PhD, futures designer Nick Foster, RDI, sleep psychologist Jade Wu, PhD, astrophysicist and astrobiologist Dr. Lisa Kaltenegger, and broadcaster and author Krista Tippett.

More news about: Unlikely Collaborators


Mar 26, 2026, 07:51 ET ChinaAMC celebrates the power of AI by launching major events

disruption?Ya-Qin Zhang, founding dean of Institute for AI Industry Research, Tsinghua University, Zhu Yi, Assistant General Manager, ChinaAMC, and Wu Chaoze, member of the Executive Committee, China Securities, sat down and shared their views centered around "A New Paradigm of AI".Zhu

More news about: ChinaAMC


Mar 26, 2026, 04:00 ET Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)

Populations Hongyi Zhao, Jiaming Sun, Wenyu Wu, Qian Tan, Shu-Hung Huang, Tim-Mo Chen, Mana Hirayama, Ziyang Liu, Chung-Yi C. Chiang, Yoko Suzuki, Bryan Ho, Amy S. Weitzenfeld,

More news about: AbbVie


Mar 25, 2026, 20:50 ET Human Longevity, Inc. and LEV Foundation Announce Strategic Collaboration to Decode Biological Drivers of Exceptional Longevity

Grey, Ph.D., are joining HLI's scientific advisory board."Centenarians and supercentenarians offer natural insights in human aging," said Wei-Wu He Ph.D., Executive Chairman at Human Longevity, Inc. "By applying our precision longevity platform to those who have achieved exceptional longevity,

More news about: Human Longevity, Inc.


Mar 25, 2026, 12:00 ET EXPLR Announces 2026 National STEM Champions as America Celebrates 250 Years of Innovation

City)Antariksha Sharma (Fairfield)KANSASSavannah Siceloff (Shawnee)KENTUCKYWanda Wu (Louisville)LOUISIANAMaya Trutschl (Shreveport)MARYLANDSathvik Dasari (Poolesville)MASSACHUSETTSJason

More news about: EXPLR


Mar 25, 2026, 04:55 ET DPC Dash Ltd Announces Full Year 2025 Financial Results

our ability to capture the significant pizza market opportunity while delivering sustainable, long-term value for our shareholders."Ms. Helen Wu, CFO of DPC Dash, added, "Our 2025 results reflect both strong top-line momentum and enhanced operating efficiency, with adjusted EBITDA growing 28.2%

More news about: DPC Dash Ltd


Mar 24, 2026, 10:59 ET Sands China Celebrates Grand Opening at Hong Kong's Art Central

private, corporate, and institutional collections worldwide.Media contacts:Corporate Communications, Sands China Ltd.Mabel WuTel: +853 8118 2268Email: [email protected] ChiangTel:

More news about: Sands China Ltd.


Mar 24, 2026, 09:00 ET Shippo Expands Shippo Intelligence with New AI-Powered Insights and Advanced Shipping Analytics

relevant to their operations."Shipping is one of the most complex and dynamic parts of running an e-commerce business," said Laura Behrens Wu, CEO and Co-founder of Shippo. "With Shippo Intelligence, we are helping merchants move beyond static reporting by surfacing the insights that matter

More news about: Shippo


Mar 23, 2026, 14:26 ET Galderma reúne profissionais injetores para apresentar as últimas tendências em estética injetável

1;17(1):83-88. 17. Kerscher M et al. Presented at IMCAS World Congress Paris, France. January 26-29, 2017 18. Wu Y et al. J Cosmet Dermatol. 2020 Jul;19(7):1627-1635. 19. Philipp-Dormston WG, et al. Dermatol Surg. 2018 Jun;44(6):826-832 20. Rzany B,

More news about: Galderma


Mar 21, 2026, 07:26 ET Dizal Announces Positive Topline Phase 3 Results from WU-KONG28 Study: Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins)

platinum-based chemotherapy. The approval in China is based on the results of the pivotal WU-KONG6 study in platinum-based chemotherapy pretreated NSCLC with EGFR exon20ins. The U.S. approval is supported by WU-KONG1 Part B, a multinational pivotal study investigating the efficacy and safety of ZEGFROVY

More news about: Dizal


Mar 20, 2026, 10:00 ET Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting

that may be made from time to time, whether as a result of new information, future developments or otherwise.For Investors:Vivian Wu[email protected] Davis, Ph.D.LifeSci

More news about: Nektar Therapeutics


Mar 19, 2026, 12:00 ET Unlikely Collaborators Hosts Peabody Award-Winning Broadcaster and Author Krista Tippett

best-selling author Lisa Feldman Barrett, PhD, neuroscientist and NYU Dean Wendy Suzuki, PhD, futures designer Nick Foster, RDI, sleep psychologist Jade Wu, PhD, and astrophysicist and astrobiologist Dr. Lisa Kaltenegger.

More news about: Unlikely Collaborators


Mar 19, 2026, 04:05 ET UP Fintech: Record Full-Year Revenue and Profit; Full-Year Profit Surges 165% YoY; Global Client Assets Reach US$60.8 Billion

inflow remained robust at US$3 billion, driving total client assets up 45.7% YoY to US$60.8 billion.UP Fintech's founder and CEO, Wu Tianhua, stated: "In 2025, the Company delivered steady growth across all business lines, while our internationalization strategy continued to progress

More news about: UP Fintech Holding Limited


Mar 18, 2026, 11:22 ET 總生存期顯著延長:蘆康沙妥珠單抗(sac-TMT) OptiTROP-Lung03研究OS最終分析結果亮相

non-small-cell lung cancer: open label, randomised, multicentre trial[J]. BMJ. 2025 Jun 5:389:e085680. doi: 10.1136/bmj-2025-085680.[2] Fang W, Wu L, Meng X, et al. Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC[J]. NEJM. 2026 Jan 1;394(1):13-26. doi: 10.1056/NEJMoa2512071.

More news about: 科倫博泰


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.